Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
The American Journal of Cardiology
|
November 27, 2016
Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level
Michael Grabner, Deborah A Winegar, Rajeshwari S Punekar, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 31, 2017
Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care
Nella Bieszk, Michael Grabner, Wenhui Wei, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 1, 2022
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosus
Tyler O'Malley, Fenglong Xie, Yujie Su, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 9, 2025
Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes
Meredith M Hoog, Carlos Vallarino, Juan M Maldonado, et al.
JMIR Cancer
|
April 12, 2021
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration
Michael Grabner, Cliff Molife, Liya Wang, et al.
Diabetes, Obesity & Metabolism
|
November 19, 2016
A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies
Wenhui Wei, Erin Buysman, Michael Grabner, et al.
BMC Gastroenterology
|
March 9, 2023
Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United States
Theresa Hunter Gibble, April N Naegeli, Michael Grabner, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction
Michael Grabner, Julja Burchard, Chi Nguyen, et al.
Psychosomatics
|
January 18, 2015
The importance of unresolved fatigue in depression: costs and comorbidities
Rebecca L Robinson, Judith J Stephenson, Ellen B Dennehy, et al.
American Health & Drug Benefits
|
May 4, 2017
Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use
Qing Huang, Michael Grabner, Robert J Sanchez, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
The American Journal of Cardiology
|
November 27, 2016
Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level
Michael Grabner, Deborah A Winegar, Rajeshwari S Punekar, et al.
Journal of Managed Care & Specialty Pharmacy
|
October 31, 2017
Personalized Care and the Role of Insulin as a Vehicle to Optimizing Treatments in Diabetes Care
Nella Bieszk, Michael Grabner, Wenhui Wei, et al.
Journal of Managed Care & Specialty Pharmacy
|
July 1, 2022
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosus
Tyler O'Malley, Fenglong Xie, Yujie Su, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 9, 2025
Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes
Meredith M Hoog, Carlos Vallarino, Juan M Maldonado, et al.
JMIR Cancer
|
April 12, 2021
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration
Michael Grabner, Cliff Molife, Liya Wang, et al.
Diabetes, Obesity & Metabolism
|
November 19, 2016
A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies
Wenhui Wei, Erin Buysman, Michael Grabner, et al.
BMC Gastroenterology
|
March 9, 2023
Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United States
Theresa Hunter Gibble, April N Naegeli, Michael Grabner, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction
Michael Grabner, Julja Burchard, Chi Nguyen, et al.
Psychosomatics
|
January 18, 2015
The importance of unresolved fatigue in depression: costs and comorbidities
Rebecca L Robinson, Judith J Stephenson, Ellen B Dennehy, et al.
American Health & Drug Benefits
|
May 4, 2017
Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use
Qing Huang, Michael Grabner, Robert J Sanchez, et al.
Page
of 9